<?xml version="1.0" encoding="UTF-8"?>
<ref id="B239-pharmaceuticals-12-00147">
 <label>239.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Burgos</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Ripoll-Gomez</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Alfaro</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Sastre</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Valdivieso</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Zebrafish as a new model for herpes simplex virus type 1 infection</article-title>
  <source>Zebrafish</source>
  <year>2008</year>
  <volume>5</volume>
  <fpage>323</fpage>
  <lpage>333</lpage>
  <pub-id pub-id-type="doi">10.1089/zeb.2008.0552</pub-id>
  <?supplied-pmid 19133831?>
  <pub-id pub-id-type="pmid">19133831</pub-id>
 </element-citation>
</ref>
